Meningitiis Antibiotics Flashcards

1
Q

Neisseria meningitides

A
  • Pathogen category: G- diplococcus, aerobic, intracellular
  • Source: human reservoir, nasopharynx, spread by respiratory droplets
  • Virulence factors: capsule (allow for it to travel through the body- petechiae and eventual purpura in patient with meningoccemia), lipoooligosaccharide (LOS), IgA protease
  • Clinical: meningococcemia
  • Immune response: antibodies to capsule; LOS triggers septic shock
  • Treatment/Prevention: vaccination to ACWY serogroups as part of standard CDC recommendation for early teens; separate later teen vaccine for B serotype for at risk individuals, including outbreaks in college dorms; rifampin prophylaxis for exposed and carriers; third generation cephalosporin as treatment, with penicillin as a traditional alternative for penicillin-susceptible strains; B vaccine more difficult to make because B antigen mimicked brain tissue

Neisseria meningitidis, the meningococcus, is a Gram-negative diplococcus that shares a number of virulence features with the gonococcus, N. gonorrhoeae, such as outer membrane proteins for adhesion. The major feature for the meningococcus is its capsule, which allows it to be distributed throughout the body, e.g., the image of petechiae and eventual purpura in a patient with meningoccemia.

Uptaken by cells then w/ strong neutrophilic response, capsule protects it from point of infection developing further and can go bacteremia w/ pilli allowing it to attach into endothelial and nerves. Petechia progressing to purpura (neutrophil response) indicate developing into sepsis.
Gonoccous (local inflammation in genital tract pyuria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acanthamoeba species

A
  • Pathogen category: free-living ameba
  • Source: natural water and soil; very widespread
  • Virulence factors: cyst formation
  • Clinical: amebic keratitis (corneal ulceration in soft contact users); meningoencephalitis (similar to Naegleria)
  • Immune response: cell-mediated response; ICP more vulnerable
  • Treatment/Prevention: changing of solutions and lenses, sterile fluid; difficult to treat, chlorhexidine + propamidine (interferes with DNA activities) for several weeks aong with possible debridement of trophozoites and cysts

Species of the free-living amoeba genus Acanthamoeba (similar to legionella can get introduced into eye feeding on epithelia and gets established) have been known to generate corneal ulceration in soft contact lens users with poor contact lens and solution hygiene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chlamydia trachomatis (eye)

A
  • Pathogen category: intracellular bacterium with LPS but not peptidoglycan
  • Source: human reservoir
  • Virulence factors: elementary body (what is released) and reticular body (intracellular) forms; depends on ATP from host cell
  • Clinical: chlamydial disease; trachoma (eye infection can be spread easily with poor hygiene; repeated infection can lead to scarring of the eyelid and subsequent corneal scaring)
  • Immune response: strong inflammatory and cell-mediated response; generated antibodies are not long-term protective
  • Treatment/Prevention: handwashing and face washing’ macrolides or doxycycline

As a reminder from the respiratory section, chlamydiae are intracellular pathogens with reticulate bodies (replicative) that then release elementary bodies to infect elsewhere. Once the body catches up to it has a strong response the response is not effectively establishing a memory (unless cleared will continue on).

Infection then strong immune response and scarring contract and pull eyelids in (entropean over the cornea developing permanently blidning or sight altering corneal abrasions).
Antibiotics- good cell uptake and prolierfation of bodies developing anti-cyclonal

There are many serotypes of chlamydia (which we will discuss more under STIs in the next part of the course), but trachoma as an eye infection can be spread easily with poor hygiene, and with repeated infections can lead to inward turning of the eyelid and subsequent corneal scarring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cryptococcus neoformans

A
  • Pathogen category: yeast (dimorphic fungi)
  • Source: environmental reservoirs (bird droppings)
  • Clinical: cryptococcal meningitis in ICP (slow onset)
  • Immune response: cell mediated
  • Treatment/Prevention: meningitis in AIDS patients: amphotericin B + flucytosine
  • Traditionally diagnosed from India ink preparation but antigen detection is more useful
  • Fluconazole used for suppression; severe cases will need amphotericin B to start

Cryptococcus neoformans (dimorphic fungi) is an inhaled fungus (hatches into yeast), and can set up a mild lung infection (pneumonia), but has a predilection for creating a meningitis in immunocompromised patients, usually only ones who develop infection. Unlike a bacterial meningitis, the onset will be slow. Exposed in pigeon dropping

Traditionally, viewing the capsule was done by an India ink preparation, such as seen here; currently, antigen detection is a more useful tool. Fluconazole useful for suppression, or for severe infections such as meningitis, patients will still need amphotericin B (with flucytosine as an inhibitor of fungal nucleic acid synthesis) initially (Sanford Guide 2019).

Ampinterase b targets ergosterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enteroviruses

A
  • Pathogen category: +ssRNA unenveloped virus (picornaviruses)
  • Source: human reservoirs
  • Virulence factors: persistence in GI tract an ongoing sheeding
  • Clinical: GI disease, often asymptomatic; depending on viremic spread, may generate other illnesses (like meningitis)
  • Immune response: post-infectious humoral
  • Treatment/Prevention: supportive care
  • Includes coxsackieviruses and echoviruses; associated with respiratory, meningeal, or cardiac illnesses (most subclinical)

The enteroviruses are common entities for viral meningitis (85%). These include coxsackieviruses and echoviruses. These are +ss RNA viruses (picornaviruses-unenveloped) that may be associated with respiratory, meningeal, or cardiac illnesses, although many infections are subclinical.

Rhinovirus- uri

Enteroviruses- taken up by the intestine, peyer patches going into lymphoid tissue that develops viremia unenveloped. (cocksackie goes into skin or heart myocarditis); poli and cocksackie into brain and spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Poliovirus

A
  • Pathogen category: unenveloped +ssRNA picornavirus
  • Source: human reservoirs
  • Virulence factors: ability to spread by oral-fecal pathways; targeting of CNS lower motor neurons
  • Clinical: polio
  • Immune response: cell-mediated and antibody responses
  • Treatment/Prevention: vaccine (killed-Salk or oral attenuated-Sabin); viral treatment not available
    As with other enteroviruses, poliovirus is also spread oral-fecally, but after the lymphatic uptake and viremic spread, preferentially targets motor neurons of the central nervous system, either by crossing the blood-brain barrier or direct neuronal ascent. The major interest in polio is the attempt to eradicate it worldwide, as the current low numbers indicate. Can spread in the water and use that as a resoervoir
    Sabin Injected vaccines. Developed in the 50s and have lately gone back to this one because of decrease in it
    Sabin oral Weakened attenuated virus covering lots of people as it is shared among the household when changing diapers (higher risk of polio from reversion) newer.
  • Oral/fecal spread then uptake by lymphatics and viremic spread
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Coxsackieviruses

A
  • Strains can be associated with pericarditis and myocarditis
    o Following viremia the virion that uptaken by those tissues

o Strong humoral/cell response to less viremic load decrease risk for cardiomyopathy

o Being chronically exposed but not clearing fully can still lead to chronic response causing the same problems

Viral infection direct cytopathic damage (bursting cell)> macrophage (IL1,2, IF-gamam, TNF, NK cells)> subclinical myocarditis cytotoxic b and t cells infecting virus creating chronic fibrotic response developing into heart failture w/ over development of the problem. If exposed and unable to clear can develop into the damaging picture (chronic lyme disease)
We saw hand-foot-and-mouth disease from coxsackieviruses as part of the respiratory items two weeks ago. Other coxsackievirus strains can be associated with pericarditis and myocarditis. Following viremia, the virions then are uptaken by those tissues. A strong humoral and cell-mediated response to lessen the viremic load would decrease the risk for cardiomyopathy. This flowchart should make sense as helping to demonstrate a combination of direct viral damage and immune response can lead to myocarditis, when there is sufficient virus present to trigger the immune activity. Overall, the rate of myocarditis is difficult to determine, e.g., 1/100,000 US population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Postnatal Conjunctivitis

A
  • Conjunctivitis- inflammation of conjunctiva
  • Keratitis- inflammation of the cornea
  • Follicles- nonspecific conjunctival response; small translucent bumps from lymphatics
  • Papillae- tissue mounds (anchors of conjunctiva by connective septa) from vascularity as from an inflammatory response
  • Staph. aureus is the most common bacterial cause accounts for discharge

o Treated with fluoroquinolone

  • Adenovirus usually viral cause and allergic conjunctivitis won’t have purulence and inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Herpes simplex keratitis

A
  • Triggers corneal scarring and blindness; ulcerations appear in a distinctive branching pattern
  • Proliferation in corneal epithelium
  • Trifluridine drops or ganciclovir gel drops for acute treatment; consider adding acyclovir or valacyclovir

Herpes simplex keratitis (infection of the cornea- dendritiic branches on the iris-corneal epithelium being more specialized developing inflammatory response at proliferation stage must recognize and treat right away) can trigger corneal scarring and blindness. The ulcerations appear in a distinctive branching pattern. Trifluridine drops (shut down prolieration) or ganciclovir ophthalmic gel would be necessary as acute treatments, with consideration of adding oral acyclovir or valacyclovir (Sanford Guide 2019).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

conjunctivitis

A

Conjunctivitis: (pinkeye); inflammation of conjunctiva
Keratitis: inflammation of the cornea
Follicles: nonspecific conjunctival response; small translucent bumps from lymphatics
Papillae: tissue mounds (as the conjunctiva are repeatedly anchored by connective septa) from vascularity as from an inflammatory response

Bacterial infections, such as those from Staphylococcus aureus (the most common), can account for discharge. Ophthalmic drops of a variety of treatments, e.g., fluoroquinolone, can be used for those. More common viral conjunctivitis (most commonly adenovirus-pink eye) or allergic conjunctivitis will not present with such purulence and inflammation (staph. Aureus-skin, petechiae- capillary leakage of pneumococcas similar to purulent sputum, h. infleunzae- associated w/ uri infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta Lactam Drugs

A

bind to PBPs (penicillin-binding protein, e.g., transpeptidases-crosslinking of sugar and dangling side chain) and thereby lead to inhibition of peptidoglycan cross-linking in cell wall synthesis.

The beta-lactam ring is opened by beta-lactamases and so loses its chemical similarity to the D-ala-D-ala when that occurs.

Beta lactam drugs are the most common means of interfering with the cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glycopeptides

A

with glycopeptides such as vancomycin representing the “step before” interference with the transpeptidation surrounding alanine side chain (dangling at end) to prevent next step.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bacitracin

A

used as a topic antibiotic (triple antibiotic ointment), with cycloserine as a rarely-used second-line TB drug, because of their toxicities onto peptide side chain in the first place .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Penicillin G

A

(the original penicillin) is given IM or IV, while penicillin V is an oral form. Different classes of penicillins depend on side groups added, which may protect against -lactamase activity. These can allow for narrow spectrum vs. broad spectrum antibiotics. In general, the penicillins are useful for Gram+ coverage.

Penicillin binding site have different cross linking going on- drug can fit right into one pathogen versus another.

Peniccilin v- oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ampcillin & Amoxacillin

A

Ampcillin-injectable vs. amOxacillin (not broken down metabolism)- bulking up to not make it easier to cancel it out
penicillin G: the natural penicillins have a short half-life, so require frequent dosing. Benzathine penicillin G is a depot form to allow for longer activity, e.g., in use for syphilis (Treponema pallidum).

the amine group makes it more polar, so as to better go through the outer membrane porins of Gram negative bacteria, but are not protecting against beta-lactamases. Amoxicillin has better oral bioavailability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pipercillin

A

has antipseudomonal activity, but has vulnerability against beta lactamases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clavulanic Acid

A

a beta-lactamase inhibitor that binds to bacterial beta-lactamases, such as seen in the amoxicillin/clavulanate mixture Augmentin®.

Beta lacatamases from harder to kill gram negative

This strategy of penicillin/beta-lactamase inhibitor can be seen in other combinations, e.g., piperacillin/tazobactam (Zosyn®) for antipseudomonal coverage.

Utilize decoy to take care of beta lactamase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cephalosporins

A

Cephalosporins tend to generate fewer hypersensitivity reactions than do the penicillins. Note that the cephalosporins have two R groups compared to the one R group of the penicillins. This potentially allows for more pharmacological manipulation of the group, e.g.,
Manipulation against beta-lactamases
Entrance through Gram-negative porins
Enhancement of PBP binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Generation of Cephalosporins

A

1st-5th generation w/ increasing generation to take care of resisting patterns. 1st generation small and utilization gram + coverage.
Cefaclor- polar group gram negative while being able to target gram +
Ceftrizone (rosephin)- gram – coverage IV/IM treating gonorrhea
Cefemine- hard to kill gram –
Ceftaroline- fight MRSA (altered peniccillin binding protein so cannot be targetted because of it only treat very severe hospital acquired MRSA infection)
Ceftolozane- similar to pyprocillin hard to kill pathogen like pseudomonas

There are several generations of cephalosporins with different antibiotic spectra.
First generation: example of cephazolin; narrow spectrum, sensitive to beta-lactamase. Used prior to surgery to decrease surgical wound infections.
Second generation: example of cefuroxime; extended spectrum, broader Gram-negative activity. Also used for preoperative surgery prophylaxis.
Third generation: example of ceftriaxone; more resistant to cephalosporinases, and more able to penetrate to the CSF compared to the first and second generation medications. Ceftriaxone is once daily (except in meningitis), to cover Gram- infections.
Fourth generation: example of cefepime; additional Gram- coverage, with continued Gram+ coverage. Used for empirical coverage of nosocomial infections.
Fifth generation: example of ceftaroline; engineered to bind to the PBP 2a of MRSA, so has MRSA coverage in addition to Gram- coverage (but not useful for Pseudomonas).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Aztreonam

A

has great aerobic Gram- coverage, as it binds well to the PBP form seen in Gram- bacteria, but no Gram+ or anaerobe coverage. More of a high end drug, it can be used for pseudomonal infections. Can go through porin and PBP of gram – so high level hospital based infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Carbapenems

A

examples of meropenem and doripenem, are powerful, broad-spectrum antibiotics, e.g., for empirical coverage of a mixed infection in a seriously ill patient while awaiting culture results. Again, these are high-end medications. High end gram posiitve and negative culture (kill everything you can) don’t use for routine infections

These drugs also utilize a beta-lactam ring, but have different side chains and overall size, which allows:
Resistance to β-lactamases
Wide affinity for different PBPs
Ability to pass through Gram- porins

Unnervingly, there are increasing reports of organisms such as Klebsiella pneumoniae with a New Delhi metallo-beta-lactamase 1 (NDM-1) that deactivates carbapenems, as well as other specialized beta-lactamases found the CREs (carbapenem-resistant Enteriobacteriaceae) opens up beta lactam ring. These numbers are still low in the US, but climbing (380 patients with NDM-producing CRE as of December 2017), with resistance patterns of isolates being noted worldwide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vancomycin

A

A glycopeptide antibiotic that interrupts cell wall synthesis in Gram-positive bacteria by binding to the terminal alanine-alanine side chains (surrounds) and prevention of transpeptidation, in the step before the beta lactam drugs function. Rapid IV infusion triggers histamine release in a “red man syndrome.” Poorly absorbed orally, which is useful if treating Clostridum difficile infections with vancomycin (although can select for vancomycin-resistant gut organisms if used orally). Vamnocmycin too big for gram -, but need high enough concentration to work.

Vancomycin is notable for its high-end use with MRSA. Recent (May 2017) work from the Scripps Institute has led to additional modifications that could allow it to target VRE (vancomycin-resistant enterococci), although commercial production will take a while.

Can be added to inhibit sugar from adding, as well as membrane via dangling lipid tail

There are standard concerns of resistance with VRE (vancomycin-resistant enterococci) that occurs because of the altered ala-ala precursors. So far, VRSA (vancomycin-resistant S. aureus) remains rare in the US as of 2019, although there are increasing reports of VISA (vancomycin-intermediate S. aureus) strains that are also MRSA. Vchanging bottom part, vancomycin cant fit anymore

23
Q

Bacitracin

A

In contrast to the cell wall, going after the bacterial cell membrane is more difficult, as it is reasonably close to the eukaryotic cell membrane, and so could generate many side effects. These agents generally act as “detergents” to interact with and solubilize the cell membrane.

Fattty acud tail anchor in cell creating pores amphipathtic (daptomycin-cant used in secretions like surfactant because it cancels it out)
Bacitracin- systemic toxicity along the way
Colistin- interacted w/ cell membrane detergent them and dissolving them, if carbopentam resistant needed now w/ resistant

Bacitracin is an older antibiotic in current use as a topical agent (as part of “triple antibiotic therapy”). It interferes with the cycling of the carrier of peptidoglycan cell wall precursors across the cell membrane. It would be highly nephrotoxic if used systemically.

24
Q

Daptomycin

A

is a newer, high-end agent to address resistant Gram-positive pathogens, e.g., MRSA, VRE. The long fatty acid chain of daptomycin is able to intermingle with the cell membrane and disrupt it, triggering ion release, but otherwise the drug cannot fit through the porins of Gram-negative outer membranes. Pulmonary surfactant binds to daptomycin and so makes it not useful to treat MRSA pneumonia.

25
Q

Colistin

A

is an older antibiotic that has found recent “new life” as a last-ditch agent for multidrug resistant organisms, such as NDM-1-containing Klebsiella and other CREs.

26
Q

Aminoglycosides

A

are bacteriocidal given their irreversible interactions with the ribosomal 30S subunit that interferes with initiation of translation complexes. In contrast, the other anti-ribosomal drugs are typically bacteriostatic. Aerobic gram – infection have O2 dependent carrier system for the bacteria to bring them on board once in cell membrane trash the ribsoome killing cell used for serious gram negative (gentamycin-serious gram - infection and brantomycin-CF) can impact human ribosomes in the ears and kidney (deafness and renal functon are serious side effects0

The aminoglycosides are large, complex molecules. Their positively-charged nature can trigger adhesion and temporary openings through the outer membrane of G- bacteria, but to enter the cytoplasm, they must be transported across the cell membrane by an oxygen-requiring pump. They therefore are ineffective against anaerobic infections.

Most common are gentamicin and tobramycin, with broad spectrums of activity, particularly against aerobic G- bacteria. Given the need for intracellular location in order to work, aminoglycosides are often synergistically combined with penicillins (“amp and gent” [ampicillin and gentamicin] combination), as for Listeria monocytogenes, an aerobic G+ organism.

Nephrotoxicity and ototoxicity are two well-recognized side effects of aminoglycosides that are dose-related.

27
Q

Tetracyclines

A

are big but good tissue penetration (impacts ribosome)
Broad-spectrum, but bacteriostatic by interfering with tRNA/ribosomal binding in the 30S (trna binds to this subunit) subunit preventing trna binding to. Tetracyclines are calcium chelators, hence their side effect of affecting bone and teeth (photosensitizing cant go out in sun). They are therefore contraindicated in young children (except for potentially lethal illnesses like Rocky Mountain spotted fever) and pregnancy. The calcium chelating activity means that taking them with calcium, iron, etc. will decrease their bioavailability.

The tetracyclines are taken up by bacteria both passively (the molecule is lipophilic at physiological pH) and via an energy-dependent transport mechanism from the cell membrane.

Doxycycline is well absorbed from the GI tract and so is a popular form, as seen with use against chlamydias, mycoplasmas, tick-borne diseases, etc.

28
Q

Macrolides

A

macrolides (such as azithromycin):
Bacteriostatic antibiotics that block peptide elongation as well by binding to the 50S subunit. The macrolides are broad coverage medications that are readily uptaken into host cells, including macrophages, and so are the drug of choice for several situations (e.g., community-acquired pneumonias), but with a well-known reputation for GI upset, as their structures act as a motilin receptor agonist. Preventing elongation of the peptide chain.
Z-pac ones a day high tissue concentration- good tissue penetration. Covering community acquired pneumonia as well as pneumococcys
There has been a FDA black box warning as of March 2013 on risk of azithromycin with QT prolongation and torsades de pointes, with the underlying NEJM study showing that this risk was higher in those with existing cardiac conditions.
As with aminoglycosides and tetracyclines, there is a separate bacterial uptake mechanism for the macrolides.

29
Q

Chloramphenicol

A

Another broad spectrum antibiotic with bacteriostatic effects on blocking peptide elongation with binding to the 50S subunit. Blood dyscrasias are a rare, but definite risk factor, as is gray baby syndrome from accumulation, so not used very often in the US. Chloramphenicol IV can be used in occasional cases where there is a need to cross an inflamed blood-brain barrier, e.g., meningococcal meningitis, if there is a severe penicillin allergy. There is also a possible use as an alternative to doxycycline in pregnant women with Rocky Mountain spotted fever (Sanford Guide 2019). Can get down into bone marrow causing aplastic anemia w/ negative dangerous potential side effects but second or third line agent of pathogens that require necessary shut down (severe penicillin alelrgies for meningitis)

30
Q

Clindamycin

A

(a lincosamide):
More peptide elongation cessation by binding to 50S ribosome at the same spot as erythromycin; a combination of aerobic Gram positive and anaerobic coverage, as with oral infections (oral prophylaxis), or topically with acne (benzoclin and clindamycin). Concern surrounds its use with its likelihood to induce pseudomembranous colitis with Clostridium difficile, although other antibiotics can trigger that as well.

31
Q

Linezolid

A

blocks the 50S ribosome in a way that prevents the formation of a functioning 70S complex. This difference in approach can make it an option in VRE or MRSA. It can inhibit monoamine oxidase (MAO) and so trigger a serotonin syndrome reaction if given to someone on SSRIs.

32
Q

Mupirocin

A

(Bactroban®) is useful for topical Gram+ coverage, including MRSA (think of our discussion of impetigo). It interferes with the linkage of an amino acid to its tRNA (isoleucyl t-RNA synthetase) and so inhibits protein synthesis less resistance but is a step ahead.

33
Q

Quinolones

A

work by interfering with DNA topoisomerases (DNA gyrase and topoisomerase IV).

The quinolones high affinity for bacterial uncoilers killing them, are popular antibiotics with a number of illnesses, such as Pseudomonas and anthrax, given their overall efficacy. They are not the choice of children, unless for serious illness, as they can (theoretically) accumulate in growing cartilage and damage it. In addition, their use has been associated with tendonitis in older adults, and in particular, Achilles tendinopathy. In addition, there can be peripheral neuropathy issues, kids cartilage (rare side effects). Don’t use high end for first line. As a result, in May 2016, the FDA issued a bulletin indicating a change in quinolone warning labels to discourage their use where there are treatment options available. with ongoing monitoring of their possible side effects. Broad protective useful in the spectrum.

As with the tetracyclines, the quinolones are cation chelators, so that taking them with calcium, iron, etc., will decrease their bioavailability.

34
Q

Ciprofloxacin

A

tissue (fluoroquinoloine) Ciprofloxacin, with a wide spectrum of coverage including the Gram- rods including Pseudomonas, is the best known of the quinolones

35
Q

Moxifloxacin

A

respiratory Moxifloxacin and levofloxin have better coverage of pneumococcus, so can be used in community-acquired pneumonia (but not as first choice, given the recent FDA warning above).

36
Q

Metronidazole

A

Works under anaerobic situations (as the drug is then reduced) to produce compounds that disrupt bacterial DNA. As a result, a useful drug for anaerobes (although you may know it better as Flagyl® and its target of protozoa). Given that it inhibits aldehyde dehydrogenase, it can trigger a disulfuram-type reaction. Low oxygen environments redox reaction that trash DNA level of metabolites and trashing with single cell amoeba and giardia. Shut down alcohol dehydrogenase (otherwise will vomit alcohol cannot be taken)

37
Q

Tinidazole

A

has a shorter treatment course than metronidazole, but is more expensive. Easier dosing for day and better tissue side effect profile.

38
Q

nitrofurantoin

A

(macrodantin and macrobid)- specialized for combatting UTI. Taken into the bacterial cell and is metabolized into reactive intermediates that affect DNA. These nitrofurantoin intermediates may also attack ribosomes. Nitrofurantoin is an oral antibiotic which is concentrated in urine; appropriate for acute uncomplicated cystitis only. Pulmonary side effects can occur, both acute and chronic. High O2 environments metabolite may trash and cause cellular damage due to pulmonary responses (anaphylactic and firbosis) side effects.

39
Q

Antimetabolites

A

such as sulfonamides prevent synthesis of folic acid (mammalian cells cannot synthesize it, and so this activity preferentially targets bacteria).

40
Q

Trimethoprim

A

interferes with folic acid metabolism at another point in the pathway, so that the combination of use of a sulfonamide such as sulfamethoxazole (bactrim) can be appropriate. They are often used in uncomplicated UTIs, but also have use in AIDS patients for prophylaxis/treatment against Pneumocystis. Dermatological side effects, including Stevens-Johnson syndrome, can occur.

41
Q

Dapsone

A

is used for treating leprosy; it has an anti-inflammatory effect by impacting the respiratory burst activity seen in neutrophils.

42
Q

Antituberculosis drugs. TB, Mycobacterium tuberculosis

A

, is a major health concern, as the organisms have the unusual cell wall (with mycolic acid-waxiness) of the acid-fast bacteria, a slow rate of growth, and treatment need to penetrate the caseating granulomas that the body generates in response to them. As a result, combination therapy and prolonged duration of treatment mark anti-TB regimens.

43
Q

Isoniazid (INH)

A

Inhibits the synthesis of mycolic acids. As a result, it is bactericidal for mycobacteria. Given resistance issues, INH is typically taken in combination as well for treatment of active TB. Neural and hepatic toxicity. Addition of pyridoxine (vitamin B6) is considered to minimize the peripheral neurotoxicity.

44
Q

Ethambutol

A

Inhibits an enzyme in the production of arabinogalactans, which help to hold mycolic acids in place as part of the cell wall. When their synthesis and the arabinogalactan/mycolic acid complex is disrupted, the mycobacterial cell wall is now more permeable. Causes dose-related optic neuritis (think of the parallel with drinking methanol). Alcohol to aldehyde to acid (ethambutol toxic metabolites can then damage eye sight when broken down need opthamologic.

45
Q

Pyrazinamide

A

A modified nicotinamide that interferes with mycolic acid production, with hepatic toxicity. Short chain fatty acid precursor therefore can lead to hepatic toxiciity

46
Q

Rifampin

A

Inhibits the initiation of mRNA synthesis by inhibiting the DNA-dependent RNA polymerase in bacteria. Rifampin is bactericidal for TB. As with the other TB drugs, it needs to be used as a combined therapy as rifampin resistance arises rapidly, given that a single mutation can affect its “fit” preferentially targetting RNA polymerase of bacteria (can very easily incur resistance in single change that’s why it needs to be used in combination.

Side effects: it turns secretions red or orange (tears, sweat which will clear up), and as it is a potent cytochrome P450 inducer, rifampin may lead to altered dosing of other drugs.

47
Q

Acyclovir

A

is a nucleoside analog/DNA chain terminator that can not be incorporated well by normal cells, but can be incorporated by the viral thymidine kinase of HSV and VZV (varicella-zoster) leading to chain determination , remembering that these herpesviruses will make their own for the epithelial proliferation phase of their life cycles.
Acyclovir is poorly absorbed, and so requires frequent PO dosing, but can be given IV, e.g., for herpes encephalitis.

48
Q

valacyclovir

A

Prodrug forms such as valacyclovir have better PO and absorption characteristics, following a hepatic first-pass effect.

49
Q

Amantadine

A

treats influenza A by affecting the viral protein M2 required for uncoating (as it is an ion channel useful in the acidified endosome) plugs the pore of an endosome that would acidify endosome so it didn’t uncoat. Unfortunately, amantadine needs to be taken right at the time of infection. With antigenic drift, one runs into problems with M2 proteins being altered, such that there are high patterns of resistance worldwide (dumping tons on chicken farms). Don’t use it

50
Q

Oseltamivir

A

(Tamiflu®, oral) and zanamivir (Relenza®, inhalable) and are neuraminidase inhibitors that can shorten a flu infection by decreasing the release of virus, as the neuraminindase helps to “cut through” sialic acid residues and allow virion spread to other respiratory cells. Oseltamivir can cause GI symptoms, but zanamivir can cause cough and bronchospasm, given how they are taken.

51
Q

baloxavir

A

(Xofluza®, single dose, oral) has an interesting mechanism of inhibiting the viral cap endonuclease. Briefly, the virus will snag the 5’ end of host mRNAs with the endonuclease to cap viral mRNAs and hence prime them to run through the host ribosomes. Endonuclease inhibitor shutting down function of flu virus, enough tissue penetration prevent from replicating as it cant snip primer ends of RNA doesn’t run through so easily making it less proliferation.

52
Q

Ergosterol

A

Ergosterol is a different sterol than cholesterol, as seen in the above pathway. This is the main basis for most of the antifungal drugs. In particular, the conversion of lanosterol to ergosterol by the fungal P450 enzyme lanosterol 14 alpha demethylase will be the key target for the azole drugs- interfere w/ synthesis pathway of it.

53
Q

Terbinafine

A

is a dermatophyte drug that impacts squalene epoxidase, an earlier step in the ergosterol synthesis process used for more embedded dermatophyte infection.

54
Q

Amphotericin B

A

(and nystatin) bind to ergosterol that is already in the fungal cell membrane to create disruptions. Numerous infusion reactions and nephrotoxicity are associated with amphotericin B use. Different formulations exist, e.g., lipid dispersal, to try to minimize these toxicities, and practitioners would need to be aware of different concentrations as a result. Polar and nonpolar side binding to it so that the ergosterol binds against crating a water channel creating pore w/ preexisting ergosterol in membrane have. Affects human cells and side effects don’t use unless evere established fungal infection